Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Corneal Transplantation | 13 | 2024 | 321 | 3.730 |
Why?
|
Dry Eye Syndromes | 17 | 2022 | 385 | 3.230 |
Why?
|
Corneal Diseases | 10 | 2024 | 536 | 2.240 |
Why?
|
Cornea | 19 | 2024 | 1326 | 1.580 |
Why?
|
Corneal Dystrophies, Hereditary | 3 | 2022 | 63 | 1.080 |
Why?
|
Keratitis | 4 | 2022 | 239 | 1.000 |
Why?
|
Keratoplasty, Penetrating | 6 | 2024 | 144 | 0.990 |
Why?
|
Glaucoma, Angle-Closure | 2 | 2017 | 191 | 0.950 |
Why?
|
Corneal Neovascularization | 3 | 2022 | 185 | 0.930 |
Why?
|
Trigeminal Nerve Diseases | 2 | 2022 | 49 | 0.910 |
Why?
|
Tears | 6 | 2022 | 251 | 0.850 |
Why?
|
Cataract | 3 | 2022 | 827 | 0.850 |
Why?
|
Cataract Extraction | 2 | 2017 | 465 | 0.810 |
Why?
|
Corneal Perforation | 4 | 2022 | 29 | 0.750 |
Why?
|
Keratoconus | 1 | 2022 | 110 | 0.740 |
Why?
|
Graft vs Host Disease | 9 | 2024 | 3025 | 0.700 |
Why?
|
Epithelium, Corneal | 2 | 2020 | 248 | 0.690 |
Why?
|
Graft Survival | 7 | 2024 | 3794 | 0.690 |
Why?
|
alpha-MSH | 3 | 2024 | 71 | 0.670 |
Why?
|
Angiogenesis Inhibitors | 3 | 2022 | 2049 | 0.670 |
Why?
|
Corneal Opacity | 1 | 2019 | 47 | 0.650 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2022 | 3484 | 0.640 |
Why?
|
Optics and Photonics | 1 | 2019 | 305 | 0.580 |
Why?
|
Intravitreal Injections | 1 | 2019 | 384 | 0.580 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2016 | 663 | 0.560 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2019 | 250 | 0.560 |
Why?
|
Corneal Ulcer | 3 | 2023 | 128 | 0.560 |
Why?
|
Th17 Cells | 4 | 2020 | 787 | 0.550 |
Why?
|
Eye | 3 | 2020 | 710 | 0.550 |
Why?
|
Corneal Surgery, Laser | 1 | 2016 | 11 | 0.530 |
Why?
|
Keratomileusis, Laser In Situ | 1 | 2016 | 84 | 0.480 |
Why?
|
Intraocular Pressure | 3 | 2017 | 1288 | 0.470 |
Why?
|
E-Selectin | 1 | 2016 | 576 | 0.450 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 886 | 0.440 |
Why?
|
Mice, Inbred BALB C | 13 | 2024 | 6216 | 0.440 |
Why?
|
Chemokine CCL20 | 1 | 2013 | 63 | 0.430 |
Why?
|
Receptors, CCR6 | 1 | 2013 | 73 | 0.430 |
Why?
|
Corneal Edema | 2 | 2023 | 47 | 0.430 |
Why?
|
Visual Acuity | 7 | 2024 | 2643 | 0.410 |
Why?
|
Myeloid Cells | 1 | 2017 | 820 | 0.400 |
Why?
|
Endothelium, Corneal | 4 | 2024 | 214 | 0.390 |
Why?
|
Graft Rejection | 4 | 2024 | 4426 | 0.390 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 666 | 0.390 |
Why?
|
Keratitis, Herpetic | 2 | 2022 | 77 | 0.380 |
Why?
|
Descemet Stripping Endothelial Keratoplasty | 2 | 2022 | 111 | 0.350 |
Why?
|
Conjunctiva | 7 | 2022 | 479 | 0.350 |
Why?
|
Retinal Diseases | 1 | 2016 | 702 | 0.350 |
Why?
|
Conjunctivitis | 2 | 2021 | 155 | 0.340 |
Why?
|
Hyperemia | 2 | 2021 | 221 | 0.340 |
Why?
|
Disease Models, Animal | 14 | 2024 | 18137 | 0.340 |
Why?
|
Artificial Organs | 3 | 2016 | 149 | 0.330 |
Why?
|
Mice, Inbred C57BL | 17 | 2024 | 22023 | 0.320 |
Why?
|
Eye Diseases | 3 | 2024 | 651 | 0.310 |
Why?
|
Antibodies, Neutralizing | 4 | 2024 | 1933 | 0.300 |
Why?
|
Osmolar Concentration | 2 | 2019 | 660 | 0.280 |
Why?
|
Receptors, CCR7 | 3 | 2016 | 107 | 0.270 |
Why?
|
Postoperative Complications | 3 | 2024 | 15697 | 0.270 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3735 | 0.270 |
Why?
|
Retina | 2 | 2016 | 2635 | 0.270 |
Why?
|
Cell Movement | 3 | 2017 | 5206 | 0.260 |
Why?
|
Lacrimal Apparatus | 2 | 2020 | 223 | 0.260 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2024 | 3075 | 0.250 |
Why?
|
Chemokine CCL21 | 2 | 2016 | 50 | 0.250 |
Why?
|
Anti-Allergic Agents | 2 | 2018 | 149 | 0.250 |
Why?
|
Melanocortins | 1 | 2024 | 10 | 0.230 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 2 | 2015 | 119 | 0.230 |
Why?
|
Mustard Gas | 1 | 2023 | 8 | 0.230 |
Why?
|
Receptors, Neurokinin-1 | 2 | 2022 | 132 | 0.220 |
Why?
|
Flow Cytometry | 9 | 2017 | 5870 | 0.220 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2023 | 115 | 0.210 |
Why?
|
Burns, Chemical | 1 | 2023 | 122 | 0.210 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2024 | 100 | 0.200 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2024 | 4353 | 0.200 |
Why?
|
Animals | 30 | 2024 | 167963 | 0.200 |
Why?
|
Mice | 22 | 2024 | 81208 | 0.190 |
Why?
|
Vascular Endothelial Growth Factor C | 3 | 2017 | 127 | 0.180 |
Why?
|
Eye Infections, Viral | 1 | 2021 | 60 | 0.180 |
Why?
|
Blast Injuries | 1 | 2024 | 322 | 0.180 |
Why?
|
Optic Nerve | 1 | 2023 | 567 | 0.170 |
Why?
|
Limbus Corneae | 1 | 2021 | 144 | 0.170 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 3804 | 0.170 |
Why?
|
Th1 Cells | 2 | 2015 | 1032 | 0.170 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10181 | 0.170 |
Why?
|
Interferon-gamma | 3 | 2024 | 3157 | 0.160 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2024 | 5649 | 0.160 |
Why?
|
Tissue Adhesives | 1 | 2020 | 173 | 0.160 |
Why?
|
Ophthalmic Nerve | 2 | 2015 | 42 | 0.150 |
Why?
|
Thrombospondin 1 | 1 | 2019 | 257 | 0.150 |
Why?
|
Prostheses and Implants | 2 | 2014 | 1273 | 0.150 |
Why?
|
Axons | 2 | 2023 | 1673 | 0.140 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2023 | 1112 | 0.140 |
Why?
|
Lymphangiogenesis | 2 | 2015 | 172 | 0.140 |
Why?
|
Chemokine CCL19 | 1 | 2016 | 35 | 0.130 |
Why?
|
Posterior Eye Segment | 1 | 2016 | 18 | 0.130 |
Why?
|
Matrix Metalloproteinase 9 | 2 | 2016 | 632 | 0.130 |
Why?
|
Dendritic Cells | 3 | 2016 | 2725 | 0.130 |
Why?
|
Humans | 37 | 2024 | 760621 | 0.130 |
Why?
|
Corneal Endothelial Cell Loss | 1 | 2015 | 25 | 0.120 |
Why?
|
Conjunctival Diseases | 1 | 2016 | 110 | 0.120 |
Why?
|
Keratoconjunctivitis Sicca | 1 | 2014 | 26 | 0.120 |
Why?
|
Phacoemulsification | 1 | 2017 | 149 | 0.120 |
Why?
|
Lens Implantation, Intraocular | 1 | 2017 | 190 | 0.120 |
Why?
|
Tobramycin | 1 | 2014 | 67 | 0.120 |
Why?
|
Military Personnel | 1 | 2024 | 1244 | 0.120 |
Why?
|
Methylprednisolone | 1 | 2016 | 384 | 0.120 |
Why?
|
DNA Damage | 1 | 2024 | 2442 | 0.120 |
Why?
|
Aqueous Humor | 1 | 2014 | 153 | 0.120 |
Why?
|
Wound Healing | 2 | 2023 | 2788 | 0.110 |
Why?
|
P-Selectin | 1 | 2016 | 599 | 0.110 |
Why?
|
Autistic Disorder | 1 | 2023 | 1216 | 0.110 |
Why?
|
Oxidative Stress | 1 | 2024 | 3106 | 0.110 |
Why?
|
Scopolamine | 1 | 2013 | 94 | 0.110 |
Why?
|
Immunosuppressive Agents | 2 | 2016 | 4166 | 0.110 |
Why?
|
Androstadienes | 1 | 2014 | 348 | 0.110 |
Why?
|
Tacrolimus | 1 | 2016 | 733 | 0.100 |
Why?
|
Cell Proliferation | 3 | 2017 | 10446 | 0.100 |
Why?
|
Fluorophotometry | 3 | 2018 | 40 | 0.100 |
Why?
|
Optic Nerve Diseases | 1 | 2016 | 342 | 0.100 |
Why?
|
Phosphodiesterase 4 Inhibitors | 1 | 2012 | 34 | 0.100 |
Why?
|
Lymphoid Tissue | 1 | 2013 | 445 | 0.100 |
Why?
|
Interleukin-7 | 1 | 2012 | 142 | 0.100 |
Why?
|
Nerve Degeneration | 1 | 2016 | 748 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2016 | 600 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2014 | 928 | 0.100 |
Why?
|
Extracellular Matrix | 1 | 2019 | 1726 | 0.100 |
Why?
|
Ophthalmic Solutions | 3 | 2021 | 304 | 0.090 |
Why?
|
Microscopy, Confocal | 4 | 2023 | 1972 | 0.090 |
Why?
|
Immune Tolerance | 2 | 2024 | 2299 | 0.090 |
Why?
|
Fluorescein | 2 | 2022 | 174 | 0.090 |
Why?
|
Transplantation, Homologous | 5 | 2017 | 4810 | 0.090 |
Why?
|
Lymph Nodes | 3 | 2016 | 3486 | 0.080 |
Why?
|
Time Factors | 5 | 2021 | 40165 | 0.080 |
Why?
|
Male | 25 | 2024 | 359744 | 0.080 |
Why?
|
Mice, Inbred C3H | 2 | 2024 | 915 | 0.080 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2014 | 498 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2024 | 80372 | 0.080 |
Why?
|
RNA | 3 | 2016 | 2722 | 0.080 |
Why?
|
Interleukin-2 | 1 | 2016 | 1889 | 0.080 |
Why?
|
Ligands | 1 | 2016 | 3276 | 0.080 |
Why?
|
Models, Animal | 1 | 2015 | 2117 | 0.080 |
Why?
|
Glucocorticoids | 1 | 2018 | 2145 | 0.080 |
Why?
|
Female | 21 | 2024 | 391270 | 0.080 |
Why?
|
Registries | 1 | 2024 | 8469 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2250 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2015 | 1336 | 0.070 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11903 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2016 | 1881 | 0.070 |
Why?
|
Macrophages | 2 | 2023 | 5745 | 0.070 |
Why?
|
Neovascularization, Pathologic | 1 | 2017 | 2640 | 0.070 |
Why?
|
Transplantation, Isogeneic | 2 | 2017 | 248 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1796 | 0.070 |
Why?
|
Antigen-Presenting Cells | 2 | 2023 | 967 | 0.060 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5496 | 0.060 |
Why?
|
Disease Management | 1 | 2016 | 2514 | 0.060 |
Why?
|
Receptors, Melanocortin | 1 | 2024 | 23 | 0.060 |
Why?
|
Endothelial Cells | 3 | 2023 | 3539 | 0.060 |
Why?
|
Signal Transduction | 3 | 2017 | 23376 | 0.060 |
Why?
|
Mechlorethamine | 1 | 2023 | 129 | 0.060 |
Why?
|
Mesenchymal Stem Cells | 1 | 2014 | 1634 | 0.060 |
Why?
|
Cell Line | 3 | 2024 | 15620 | 0.060 |
Why?
|
Prospective Studies | 4 | 2022 | 54303 | 0.050 |
Why?
|
Tissue Preservation | 1 | 2023 | 174 | 0.050 |
Why?
|
Cytoprotection | 1 | 2023 | 200 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2023 | 4357 | 0.050 |
Why?
|
Streptozocin | 1 | 2023 | 194 | 0.050 |
Why?
|
Eye Pain | 1 | 2022 | 46 | 0.050 |
Why?
|
Descemet Membrane | 1 | 2022 | 71 | 0.050 |
Why?
|
Middle Aged | 11 | 2022 | 220352 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2017 | 1342 | 0.050 |
Why?
|
Substance P | 1 | 2022 | 333 | 0.050 |
Why?
|
Neutrophil Infiltration | 1 | 2023 | 393 | 0.050 |
Why?
|
Hydrogen Peroxide | 1 | 2024 | 732 | 0.050 |
Why?
|
Chronic Disease | 3 | 2021 | 9287 | 0.050 |
Why?
|
Cyanoacrylates | 1 | 2020 | 46 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2023 | 979 | 0.040 |
Why?
|
Prevalence | 3 | 2022 | 15687 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2012 | 3047 | 0.040 |
Why?
|
Interleukin-1beta | 2 | 2016 | 998 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2024 | 1078 | 0.040 |
Why?
|
Risk Factors | 4 | 2021 | 74359 | 0.040 |
Why?
|
Cytokines | 3 | 2020 | 7343 | 0.040 |
Why?
|
Cell Death | 1 | 2024 | 1672 | 0.040 |
Why?
|
Inflammation | 3 | 2024 | 10756 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9185 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2018 | 12427 | 0.040 |
Why?
|
Environment | 1 | 2024 | 1118 | 0.040 |
Why?
|
Aged | 8 | 2023 | 169152 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2014 | 2135 | 0.040 |
Why?
|
Rabbits | 1 | 2023 | 4773 | 0.040 |
Why?
|
Gene Expression | 2 | 2022 | 7588 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7408 | 0.030 |
Why?
|
Vision Disorders | 1 | 2023 | 1084 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1765 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2014 | 11071 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2016 | 18957 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2021 | 58995 | 0.030 |
Why?
|
Meibomian Glands | 1 | 2014 | 73 | 0.030 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2016 | 305 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2014 | 64 | 0.030 |
Why?
|
Miniaturization | 1 | 2014 | 153 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2017 | 544 | 0.030 |
Why?
|
Eye Burns | 1 | 2014 | 65 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2575 | 0.030 |
Why?
|
Administration, Topical | 1 | 2016 | 697 | 0.030 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2014 | 516 | 0.030 |
Why?
|
Adolescent | 4 | 2024 | 87810 | 0.030 |
Why?
|
Glaucoma | 1 | 2023 | 1182 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2018 | 1089 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2016 | 822 | 0.030 |
Why?
|
Corneal Stroma | 1 | 2014 | 171 | 0.030 |
Why?
|
Eyelid Diseases | 1 | 2014 | 157 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 65017 | 0.030 |
Why?
|
Isoantigens | 1 | 2014 | 552 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4541 | 0.020 |
Why?
|
Cyclohexanecarboxylic Acids | 1 | 2012 | 140 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42063 | 0.020 |
Why?
|
Cell Count | 1 | 2015 | 1835 | 0.020 |
Why?
|
Adult | 6 | 2021 | 219994 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2016 | 12766 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 58741 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2014 | 975 | 0.020 |
Why?
|
Membrane Transport Proteins | 1 | 2014 | 1035 | 0.020 |
Why?
|
Forkhead Transcription Factors | 1 | 2016 | 1612 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8803 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2016 | 4899 | 0.020 |
Why?
|
Apoptosis | 1 | 2023 | 9501 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2651 | 0.020 |
Why?
|
Nitriles | 1 | 2012 | 956 | 0.020 |
Why?
|
Glycoproteins | 1 | 2014 | 2208 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39261 | 0.020 |
Why?
|
Autoimmunity | 1 | 2014 | 1370 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2283 | 0.020 |
Why?
|
United States | 2 | 2024 | 72461 | 0.020 |
Why?
|
Incidence | 1 | 2024 | 21392 | 0.020 |
Why?
|
Child | 2 | 2024 | 79806 | 0.020 |
Why?
|
Patient Selection | 1 | 2017 | 4283 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6498 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3448 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26181 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2017 | 5508 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11481 | 0.010 |
Why?
|
Infant | 1 | 2024 | 36060 | 0.010 |
Why?
|
Pregnancy | 1 | 2023 | 29749 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13308 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2017 | 7475 | 0.010 |
Why?
|
Disease Progression | 1 | 2012 | 13502 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2015 | 25942 | 0.010 |
Why?
|